Tao Wen

5.4k total citations · 1 hit paper
114 papers, 3.8k citations indexed

About

Tao Wen is a scholar working on Molecular Biology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tao Wen has authored 114 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 62 papers in Molecular Biology, 36 papers in Immunology and 20 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tao Wen's work include Glycosylation and Glycoproteins Research (14 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers) and Galectins and Cancer Biology (13 papers). Tao Wen is often cited by papers focused on Glycosylation and Glycoproteins Research (14 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (13 papers) and Galectins and Cancer Biology (13 papers). Tao Wen collaborates with scholars based in China, United States and Singapore. Tao Wen's co-authors include Xiaoli Ru, Feng He, Jian Liu, Zongmei Wen, Zhao Jin-yuan, Li Guan, Yanlin Zhang, Xiuhui Li, Guangyu An and Lina Li and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Tao Wen

110 papers receiving 3.7k citations

Hit Papers

NRF2, a Transcription Fac... 2020 2026 2022 2024 2020 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tao Wen China 30 2.2k 647 542 463 378 114 3.8k
Xiuwen Tang China 32 2.8k 1.2× 405 0.6× 388 0.7× 344 0.7× 270 0.7× 70 4.2k
Young‐Chae Chang South Korea 38 2.2k 1.0× 518 0.8× 641 1.2× 486 1.0× 192 0.5× 151 4.4k
Jiunn‐Liang Ko Taiwan 39 2.3k 1.0× 439 0.7× 648 1.2× 455 1.0× 544 1.4× 184 4.7k
Rong Hu China 38 2.1k 0.9× 738 1.1× 489 0.9× 286 0.6× 248 0.7× 117 3.7k
Tian Lan China 38 2.3k 1.1× 630 1.0× 892 1.6× 920 2.0× 338 0.9× 134 4.5k
Yong Lin United States 29 2.0k 0.9× 586 0.9× 819 1.5× 386 0.8× 336 0.9× 67 3.7k
Johannes M. Breuss Austria 33 2.5k 1.1× 710 1.1× 776 1.4× 257 0.6× 301 0.8× 66 5.6k
Hui‐Ling Chiou Taiwan 36 1.9k 0.8× 386 0.6× 701 1.3× 545 1.2× 351 0.9× 94 3.8k
Yue Dai China 43 2.3k 1.1× 706 1.1× 400 0.7× 400 0.9× 289 0.8× 185 5.2k
Yueshui Zhao China 33 1.5k 0.7× 502 0.8× 618 1.1× 370 0.8× 328 0.9× 116 3.3k

Countries citing papers authored by Tao Wen

Since Specialization
Citations

This map shows the geographic impact of Tao Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tao Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tao Wen more than expected).

Fields of papers citing papers by Tao Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tao Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tao Wen. The network helps show where Tao Wen may publish in the future.

Co-authorship network of co-authors of Tao Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Tao Wen. A scholar is included among the top collaborators of Tao Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tao Wen. Tao Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Deng, Qing, Yu Ji, Jian Li, & Tao Wen. (2025). Lipid reprogramming and ferroptosis crosstalk in clear cell renal cell carcinoma: metabolic vulnerabilities and therapeutic targeting. Molecular Cancer. 24(1). 236–236. 1 indexed citations
5.
Yu, Minhao, Yalin Cheng, Tao Wen, et al.. (2024). A Novel Scale for Diagnosis of Pulmonary Ground‐Glass Nodules: A Multicenter and Ambispective Cohort Study. The Clinical Respiratory Journal. 18(11). e70027–e70027. 1 indexed citations
6.
Wang, Sheng, Tao Wen, Cheng Zhang, et al.. (2024). Tumour burden score combined with albumin‐to‐alkaline phosphatase ratio predicts prognosis in patients with intrahepatic cholangiocarcinoma. Journal of Cellular and Molecular Medicine. 28(13). e18530–e18530. 3 indexed citations
7.
Wen, Tao, Weiming Deng, Lingxiao Zhang, et al.. (2023). Plasma extracellular vesicle circRNA signature and resistance to abiraterone in metastatic castration-resistant prostate cancer. British Journal of Cancer. 128(7). 1320–1332. 8 indexed citations
8.
Tan, Jing‐Yu, et al.. (2023). Tn antigen promotes breast cancer metastasis via impairment of CASC4. Cell Biology International. 47(11). 1854–1867. 5 indexed citations
10.
He, Tao, et al.. (2022). CircSCAF8 promotes growth and metastasis of prostate cancer through the circSCAF8-miR-140-3p/miR-335-LIF pathway. Cell Death and Disease. 13(6). 517–517. 18 indexed citations
11.
Liu, Qun, Zhenguo Zhao, Ruijun Li, et al.. (2022). Combined Usage of MDK Inhibitor Augments Interferon-γ Anti-Tumor Activity in the SKOV3 Human Ovarian Cancer Cell Line. Biomedicines. 11(1). 8–8. 9 indexed citations
12.
Jia, Xingyuan, Xiaoli Ru, Lina Li, et al.. (2020). <p>Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44</p>. Cancer Management and Research. Volume 12. 511–522. 13 indexed citations
13.
Du, Tingting, Xueyuan Jia, Xuesong Dong, et al.. (2020). Cosmc Disruption-Mediated Aberrant O-glycosylation Suppresses Breast Cancer Cell Growth via Impairment of CD44. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Liu, Jian, Chunxiao Li, Jinsong Wang, et al.. (2020). Chromatin modifier MTA1 regulates mitotic transition and tumorigenesis by orchestrating mitotic mRNA processing. Nature Communications. 11(1). 4455–4455. 31 indexed citations
15.
He, Feng, Xiaoli Ru, & Tao Wen. (2020). NRF2, a Transcription Factor for Stress Response and Beyond. International Journal of Molecular Sciences. 21(13). 4777–4777. 1233 indexed citations breakdown →
16.
Ren, Feng, Luo Zhang, Xiuying Zhang, et al.. (2015). The dysregulation of endoplasmic reticulum stress response in acute‐on‐chronic liver failure patients caused by acute exacerbation of chronic hepatitis B. Journal of Viral Hepatitis. 23(1). 23–31. 7 indexed citations
17.
Wen, Tao, et al.. (2013). Changes of extracellular histones in mice with acute liver failure and its therapeutic potential. Zhonghua jizhen yixue zazhi. 22(2). 148–152. 1 indexed citations
18.
Wen, Tao, Liang Gao, Zongmei Wen, et al.. (2013). Exploratory investigation of plasma metabolomics in human lung adenocarcinoma. Molecular BioSystems. 9(9). 2370–2378. 51 indexed citations
19.
Wen, Tao, et al.. (2012). Morphology Evolution of Polyaniline Microstructures via Reverse Micelles and Their Hydrophobicity. Journal of Nanoscience and Nanotechnology. 12(1). 91–98. 6 indexed citations
20.
Zhang, Yanlin, Li Guan, Xifu Wang, et al.. (2008). Protection of chlorophyllin against oxidative damage by inducing HO-1 and NQO1 expression mediated by PI3K/Akt and Nrf2. Free Radical Research. 42(4). 362–371. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026